Viper antivenom is an equine-derived antivenin used to manage North American Pit viper envenomation. Viper antivenom consists of antibodies derived from horses immunized and subsequently developed antibodies against snake venoms.
- Mechanism
- Curator reviewed · 1 reference
Viper antivenom contains venom-specific F(ab’)2 fragments of immunoglobulin G (IgG) that bind and neutralize venom toxins, facilitating redistribution away from target tissues and elimination from the body.
- Primary indication
- Equine-derived viper antivenom is indicated for the management of adult and pediatric patients with North American Pit Viper envenomation.Curator reviewed · 1 structured indication
- First approval
- United States, 2015
- Also known as
- Antivenin (bothrops atrox/crotalus adamanteus/crotalus atrox/crotalus durissus terrificus) (equine) · Antivenin (crotalidae) polyvalent (equine origin) · Antivenin (crotalidae) polyvalent (equine) · Antivenin crotaline (pit-viper) equine immune F(ab)2) · Antivenin, crotalidae polyvalent, equine
- Brand names
Resolves to
Compound
Clinical / RWD
What you can answer from here — as of April 02, 2025
Which other approved drugs treat the same conditions as Viper antivenom, and which companies have late-stage candidates in those indications?
Create a free account or log in to explore the full data card.
Create Account